Vitamina D3 o diidrotachisterolo
Pubblicato il 05/06/2015
In gocce da aggiungere al cucchiaio del composto dei retinoidi nella misura di 8-10 gocce da ingerire al mattino a digiuno fino a un massimo di 30 gocce al giorno, suddivise in 10 gocce mattina, mezzogiorno e sera. Compatibilmente con la calcemia, lo stadio e l’evoluzione della patologia neoplastica, il dosaggio può essere anche triplicato.
E’ una vitamina liposolubile di cui sono state identificate 7 varietà principali tra cui le più comunemente usate in terapia sono la D2 o ergocalciferolo e la D3 o colecalciferolo. Nei tumori la massima attività è svolta dal diidrotachisterolo denominato anche A.T.10 (preparato antitetano n. 10), definizione dovuta alla tetania stato di contrattura muscolare da carenza di calcio che il diidrotachisterolo antagonizza incrementando la calcemia. E’ sinergica con retinoidi e melatonina nell’esercitare un effetto antiproliferativo, antimetastatico e proapoptotico nei tumori. Una vasta letteratura scientifica ha accertato, valorizzato e confermato la spiccata attività sia preventiva che terapeutica della vitamina D nelle patologie neoplastiche. Sono stati individuati recentemente i recettori cellulari (VDR) su cui agisce la vitamina D per esercitare i suoi effetti antineoplastici. E’ oggetto di numerosi studi una nuova generazione di vitamine D sintetiche in cui si è cercato di attenuare l’attività calcemica (che rappresenta un ostacolo in quanto l’eccesso di calcio può produrre danni gravi e non reversibili) e incrementare quella antineoplastica che è sinergica ai retinoidi anche nell’attivazione della differenziazione cellulare. E’ stato spiegato l’effetto antiproliferativo della vitamina D attraverso il blocco della mitosi cellulare in G1. E’ rilevante anche l’attivazione dell’immunità naturale e il blocco dell’angiogenesi in sinergia con le altre vitamine del protocollo MDB. Oltre che studi su linee cellulari neoplastiche in vitro e su animali, anche studi clinici ed epidemiologici hanno confermato le proprietà antitumorali della D e derivati nella prevenzione e terapia tumorale. Recentemente studi su animali prevalentemente topi e cani hanno evidenziato una potente attività anche antimetastatica della vitamina D.
Solo ricerca in vitro (organi isolati, tessuti, cellule o sistemi biochimici - definizione del libro d'oro IUPAC)
- 1979 Dec: 1,25-dihydroxyvitamin-D-receptor in breast cancer cells;
- 1980 Mar: 1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells);
- 1981 Mar: 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture;
- 1981 Aug: Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3;
- 1981 Nov: Whole-cell uptake and nuclear localization of 1,25-dihydroxycholecalciferol by breast cancer cells (T47 D) in culture;
- 1982 Mar: 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines;
- 1982 Jun: 1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60);
- 1984 Feb: 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells;
- 1984 Jul: Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells;
- 1984 Dec: Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues;
- 1985 Jun: 1 alpha, 25-dihydroxyvitamin D3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line;
- 1986 Jan: 1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20);
- 1987 Mar: Regulation of cellular adhesion and fibronectin synthesis by 1 alpha,25-dihydroxyvitamin D3;
- 1988 Dec: Regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D3 in human osteosarcoma cells;
- 1991 Jan: Role of intracellular-free calcium in the cornified envelope formation of keratinocytes: differences in the mode of action of extracellular calcium and 1,25 dihydroxyvitamin D3;
- 1991 May: 1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production;
- 1991 Aug: A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia;
- 1992 Aug: Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro;
- 1992 Sep: Growth control of human colon cancer cells by vitamin D and calcium in vitro;
- 1993 May: Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines;
- 1993 Oct: Stabilization of the vitamin D receptor in rat osteosarcoma cells through the action of 1,25-dihydroxyvitamin D3;
- 1993 Oct: The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma;
- 1993 Nov: Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combination;
- 1994 Feb: Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells;
- 1994 Mar: Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms;
- 1994 May: 1 alpha,25-Dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro;
- 1994 Oct: 1,25-dihydroxyvitamin D3 receptors in normal and malignant human colorectal tissues;
- 1994 Dec: 1,25-Dihydroxyvitamin D3 potentiates the cytotoxic effect of TNF on human breast cancer cells;
- 1995 Jan: Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3;
- 1995 Feb: 1,25-Dihydroxyvitamin D3 suppresses cell growth, DNA synthesis, and phosphorylation of retinoblastoma protein in a breast cancer cell line;
- 1995 Apr: 1,25-Dihydroxyvitamin D3 enhances the expression of transforming growth factor beta 1 and its latent form binding protein in cultured breast carcinoma cells;
- 1995 Sep: Effects of vitamin D and retinoic acid on human glioblastoma cell lines;
- 1996 Feb: Vitamin D3 analogue (EB 1089) inhibits in vitro cellular proliferation of human colon cancer cells;
- 1996 May: Stable expression of the nuclear vitamin D receptor in the human prostatic carcinoma cell line JCA-1: evidence that the antiproliferative effects of 1 alpha, 25-dihydroxyvitamin D3 are mediated exclusively through the genomic signaling pathway;
- 1996 May: Vitamin D inhibits endothelial cell migration;
- 1996 Jun: Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells;
- 1996 Jul: 1,25-Dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in MCF-7 breast cancer cells;
- 1996 Jul: Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells;
- 1997 Feb: Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines;
- 1997 Apr: 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1;
- 1997 May: Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines;
- 1997 Aug: The in vitro effect of vitamin D3 analogue EB-1089 on a human prostate cancer cell line (PC-3);
- 1997 Sep: 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells;
- 1997 Oct: 1,25-Dihydroxyvitamin D3 and its analogues inhibit acute myelogenous leukemia progenitor proliferation by suppressing interleukin-1beta production;
- 1997 Oct: Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro;
- 1997 Dec: Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system;
- 1998 Mar: Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation;
- 1998 Apr: 1,25-Dihydroxyvitamin D3 inhibits tenascin-C expression in mammary epithelial cells;
- 1998 Aug: Combinational effects of vitamin D3 and retinoic acid (all trans and 9 cis) on proliferation, differentiation, and programmed cell death in two small cell lung carcinoma cell lines;
- 1998 Nov: Apoptosis induction of POS canine osteosarcoma cells by vitamin D and retinoids;
- 1998 Nov: Expression of 1,25-dihydroxy vitamin D3 receptor in breast carcinoma;
- 1999 Jan: Effects of vitamin D and retinoids on the differentiation and growth in vitro of canine osteosarcoma and its clonal cell lines;
- 1999 Feb: 1alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma;
- 1999 Apr: 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1);
- 1999 Jun: 1,25-Dihydroxyvitamin D3, recombinant human transforming growth factor-beta 1, and recombinant human bone morphogenetic protein-2 induce in vitro differentiation of canine osteosarcoma cells;
- 1999 Jul: Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas;
- 1999 Aug: Analysis of 1,25-dihydroxyvitamin D(3) receptors (VDR) in basal cell carcinomas;
- 1999 Aug: Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells;
- 1999 Sep: Potentiation by vitamin D analogs of TNFalpha and ceramide-induced apoptosis in MCF-7 cells is associated with activation of cytosolic phospholipase A2;
- 1999 Dec: Antineoplastic activity of 1,25(OH)2D3 and its analogue 22-oxacalcitriol against human anaplastic thyroid carcinoma cell lines in vitro;
- 2000 Jan: Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2;
- 2000 Mar: 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells;
- 2000 Mar: Influence of vitamin D and retinoids on the induction of functional differentiation in vitro of canine osteosarcoma clonal cells;
- 2000 Apr: 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death;
- 2000 Apr: 1alpha,25-dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells;
- 2000 Apr: Androgen receptor and vitamin D receptor in human ovarian cancer: growth stimulation and inhibition by ligands;
- 2000 May: Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo;
- 2000 Jun: 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration;
- 2000 Jul: Differential and antagonistic effects of 9-cis-retinoic acid and vitamin D analogues on pancreatic cancer cells in vitro;
- 2000 Jul: Human leukemic (HMC-1) mast cells are responsive to 1alpha, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor;
- 2000 Aug: 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells;
- 2000 Aug: 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo;
- 2000 Oct: Prevention of renal cell carcinoma by active vitamin D3;
- 2000 Oct: The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression;
- 2000 Nov: Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist;
- 2001 Jan: 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck;
- 2001 Jan: Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo;
- 2001 Feb: Interactions of vitamin D analogue CB1093, TNFalpha and ceramide on breast cancer cell apoptosis;
- 2001 Mar: Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma;
- 2001 Mar: Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells;
- 2001 Apr: Amplification and expression of splice variants of the gene encoding the P450 cytochrome 25-hydroxyvitamin D(3) 1,alpha-hydroxylase (CYP 27B1) in human malignant glioma;
- 2001 Apr: Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells;
- 2001 May: 1,25-dihydroxyvitamin D3 and retonic acid analogues induce differentiation in breast cancer cells with function- and cell-specific additive effects;
- 2001 May: 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue;
- 2001 May: Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma;
- 2001 Jun: Calcipotriol inhibits autocrine phosphorylation of EGF receptor in a calcium-dependent manner, a possible mechanism for its inhibition of cell proliferation and stimulation of cell differentiation;
- 2001 Jun: Synergistic anti-proliferative effects of vitamin D derivatives and 9-cis retinoic acid in SH-SY5Y human neuroblastoma cells;
- 2001 Jul: 25-Hydroxy-Vitamin D metabolism in human colon cancer cells during tumor progression;
- 2001 Jul: Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling;
- 2001 Jul: Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1;
- 2001 Aug: Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery;
- 2001 Nov: Effects of vitamin D on the growth of normal and malignant B-cell progenitors;
- 2001 Dec: Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling;
- 2002 Jan-Feb: Analysis of vitamin D-receptor (VDR) and retinoid X-receptor alpha in breast cancer;
- 2002 Feb: Side-chain modified vitamin D analogs require activation of both PI 3-K and erk1,2 signal transduction pathways to induce differentiation of human promyelocytic leukemia cells;
- 2002 May: Degradation of RXRs influences sensitivity of rat osteosarcoma cells to the antiproliferative effects of calcitriol;
- 2002 Jul: Antiproliferative effects of 1alpha,25-dihydroxyvitamin D(3) and vitamin D analogs on tumor-derived endothelial cells;
- 2002 Oct: Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells;
- 2003 Jan: 1alpha,25(OH)2-vitamin D3 inhibits HGF synthesis and secretion from MG-63 human osteosarcoma cells;
- 2003 Feb: Analysis of the vitamin D system in cervical carcinomas, breast cancer and ovarian cancer;
- 2003 Feb: Analysis of the vitamin D system in cutaneous malignancies;
- 2003 Feb: Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation;
- 2003 Feb: Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number;
- 2003 Apr: Melatonin and vitamin D3 increase TGF-beta1 release and induce growth inhibition in breast cancer cell cultures;
- 2003 Jun: Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells;
- 2003 Aug: Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells;
- 2003 Nov: Genetic signatures of differentiation induced by 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells;
- 2003 Dec: Anti-tumor effect of vitamin A and D on head and neck squamous cell carcinoma;
- 2004 Mar: Analysis of the vitamin D system in cutaneous squamous cell carcinomas;
- 2004 May: Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays;
- 2004 Jun: Analysis of the vitamin D system in basal cell carcinomas (BCCs);
- 2004 Jun: Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3;
- 2004 Jul: Growth and EGFR regulation in breast cancer cells by vitamin D and retinoid compounds;
- 2004 Sep: Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells;
- 2005 Feb: 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer;
- 2005 Feb: Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells;
- 2005 Mar: 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia;
- 2005 May: Autocrine metabolism of vitamin D in normal and malignant breast tissue;
- 2005 Jun: 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer;
- 2005 Aug: Vitamin D(3) metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effect of calcitriol;
- 2005 Nov: 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma;
- 2005 Nov-Dec: Growth inhibition of cancer cells by an active metabolite of a novel vitamin D prodrug;
- 2006 Jan: 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases;
- 2006 Jan: Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma;
- 2006 Feb: AKT pathway is activated by 1, 25-dihydroxyvitamin D3 and participates in its anti-apoptotic effect and cell cycle control in differentiating HL60 cells;
- 2006 Aug: 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer;
- 2006 Sep: 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck;
- 2006 Sep: 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis;
- 2006 Nov: 1,25-dihydroxyvitamin D3 transcriptionally represses p45Skp2 expression via the Sp1 sites in human prostate cancer cells;
- 2007 Mar: Vitamin D regulates the phenotype of human breast cancer cells;
- 2007 Jun: 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma;
- 2007 Aug: 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma;
- 2007 Sep: Kinetic studies of 25-hydroxy-19-nor-vitamin D3 and 1 alpha,25-dihydroxy-19-nor-vitamin D3 hydroxylation by CYP27B1 and CYP24A1;
- 2007 Oct: Anti-proliferative and pro-apoptotic properties of 3-bromoacetoxy calcidiol in high-risk neuroblastoma;
- 2009 Jan: Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase, and vitamin D receptor mRNA in normal and malignant breast tissue;
- 2009 Jan: RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects;
- 2009 Feb: Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling;
- 2009 Apr: Increased UVA exposures and decreased cutaneous Vitamin D(3) levels may be responsible for the increasing incidence of melanoma;
- 2009 May: Enhancement of 1,25-dihydroxyvitamin D3- and all-trans retinoic acid-induced HL-60 leukemia cell differentiation by Panax ginseng;
- 2010 Jan: Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial;
- 2010 Feb: 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand;
- 2010 Mar: Nuclear targeting of cyclin-dependent kinase 2 reveals essential roles of cyclin-dependent kinase 2 localization and cyclin E in vitamin D-mediated growth inhibition;
- 2010 Apr: Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells;
- 2010 Jul: Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells;
- 2010 Jul: The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression;
- 2010 Jul: Vitamin D and prostate cancer: the role of membrane initiated signaling pathways in prostate cancer progression;
- 2010 Aug: Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system;
- 2010 Aug: Constitutive activation of the mitogen-activated protein kinase pathway impairs vitamin D signaling in human prostate epithelial cells;
- 2010 Aug: Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo;
- 2010 Sep: Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions;
- 2010 Nov: Melatonin and vitamin D3 synergistically down-regulate Akt and MDM2 leading to TGFβ-1-dependent growth inhibition of breast cancer cells;
- 2010 Dec: 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma;
- 2010 Dec: A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth;
- 2011 Feb: Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3;
- 2011 Mar: 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer;
- 2011 May: Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase;
- 2011 Aug: Inecalcitol, an analog of 1α,25(OH)(2) D(3), induces growth arrest of androgen-dependent prostate cancer cells;
- 2011 Dec: The novel vitamin D analog ZK191784 inhibits prostate cancer cell invasion;
- 2012 Feb: A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D;
- 2012 Apr: Attenuation of constitutive DNA damage signaling by 1,25-dihydroxyvitamin D3;
- 2012 May: Effect of 25-hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell lines;
- 2012 May: The effects of 5-fluorouracil alone and in combination with 13-cis retinoic acid and vitamin D3 on human oral squamous cell carcinoma lines;
- 2012 Jun: Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma;
- 2012 Aug: Characterization of vitamin D receptor (VDR) in lung adenocarcinoma;
- 2012 Sep: New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase;
- 2012 Oct: Clinicopathologic correlation of vitamin D receptor expression with retinoid X receptor and MIB-1 expression in primary and metastatic osteosarcoma;
- 2012 Nov: Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma;
- 2012 Dec: Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines;
- 2013 Feb: Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol;
- 2013 Apr: Synergistic effect and mechanism of vitamin A and vitamin D on inducing apoptosis of prostate cancer cells;
- 2013 May: Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells;
- 2013 Aug: Simultaneous analysis of circulating 25-hydroxy-vitamin D3, 25-hydroxy-vitamin D2, retinol, tocopherols, carotenoids, and oxidized and reduced coenzyme Q10 by high performance liquid chromatography with photo diode-array detection using C18 and C30 columns alone or in combination;
- 2013 Aug: Vitamin D analogue TX 527 down-regulates the NF-κB pathway and controls the proliferation of endothelial cells transformed by Kaposi sarcoma herpesvirus;
- 2014 Mar: Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach;
- 2014 Mar: NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells;
- 2014 Mar: Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells;
- 2014 Jun: 1α,25(OH)₂D₃ inhibits FGF-2 release from oral squamous cell carcinoma cells through down-regulation of HBp17/FGFBP-1;
- 2014 Sep: Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy;
- 2014 Sep: Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells;
- 2014 Nov: Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3;
- 2015 Feb: Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival;
- 2015 Apr: miR-145 mediates the antiproliferative and gene regulatory effects of vitamin D3 by directly targeting E2F3 in gastric cancer cells;
- 2015 Jun: 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling;
- 2015 Jun: Vitamin D3 potentiates the growth inhibitory effects of metformin in DU145 human prostate cancer cells mediated by AMPK/mTOR signalling pathway;
- 2015 Sep: Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer;
- 2015 Sep-Oct: ANTIPROLIFERATIVE AND CYTOTOXIC EFFECT OF SELECTED VITAMIN D ANALOGS ON NASAL POLYPS FIBROBLASTS AND OTHER CELLS WITH HIGHER PROLIFERATIVE POTENTIAL;
- 2015 Oct: Alterations in vitamin D signaling pathway in gastric cancer progression: a study of vitamin D receptor expression in human normal, premalignant, and malignant gastric tissue;
- 2015 Oct: Expression of Vitamin D Receptor (VDR) Positively Correlates with Survival of Urothelial Bladder Cancer Patients;
- 2016 Jan: Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines;
- 2016 Jan: Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo;
- 2016 Mar: 1,25 dihydroxyvitamin D3 inhibits the proliferation of thyroid cancer stem-like cells via cell cycle arrest;
- 2016 Mar: Regulation of vitamin D receptor expression by retinoic acid receptor alpha in acute myeloid leukemia cells;
- 2016 Apr: Vitamin D3 stimulates embryonic stem cells but inhibits migration and growth of ovarian cancer and teratocarcinoma cell lines;
- 2016 Apr: Vitamin D3 suppresses morphological evolution of the cribriform cancerous phenotype;
- 2016 May: Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer;
- 2016 Aug: 1α,25-Dihydroxyvitamin D Inhibits the Metastatic Capability of MCF10CA1a and MDA-MB-231 Cells in an In Vitro Model of Breast to Bone Metastasis;
- 2016 Aug: 1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition;
- 2017 Jan: Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications;
- 2017 Jan: Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis;
- 2017 Jun: 1,25-Dihydroxyvitamin D3 suppresses gastric cancer cell growth through VDR- and mutant p53-mediated induction of p21;
- 2017 Jul: 1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p;
- 2017 Sep: Calcitriol exerts an anti-tumor effect in osteosarcoma by inducing the endoplasmic reticulum stress response;
- 2017 Nov: 1,25(OH)2D3 deficiency increases TM40D tumor growth in bone and accelerates tumor-induced bone destruction in a breast cancer bone metastasis model;
- 2018 Feb: Effects of Combined Treatment with Vitamin D and COX2 Inhibitors on Breast Cancer Cell Lines;
- 2018 Feb: Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model;
- 2018 Mar: Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)₂D₃: Is It Really the Vitamin D₃ Upregulated Protein?;
- 2018 Mar: Depleting ovarian cancer stem cells with calcitriol;
- 2018 Apr: MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin;
- 2018 Apr: Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5;
- 2018 Jul: Calcitriol and Calcidiol Can Sensitize Melanoma Cells to Low⁻LET Proton Beam Irradiation;
- 2018 Jul: Vitamin D and DDX4 regulate the proliferation and invasion of ovarian cancer cells;
- 2018 Sep: Effect of Vitamin D on Paclitaxel Efficacy in Triple-negative Breast Cancer Cell Lines;
- 2018 Sep: Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study;
- 2018 Dec: Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients;
- 2019 Feb: Growth inhibition and apoptosis in colorectal cancer cells induced by Vitamin D-Nanoemulsion (NVD): involvement of Wnt/β-catenin and other signal transduction pathways;
- 2020 Mar: Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2;
- 2020 Jul: An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis;
- 2020 Sep: Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All- Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines;
- 2020 Sep: Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer;
- 2020 Dec: Chemopreventive effects of vitamin D 3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules;
- 2021 Feb: Evaluation of the potential anticancer activity of different vitamin D metabolites on colorectal and breast cancer cell lines;
- 2021 Jul: Calcitriol Promotes Differentiation of Glioma Stem-Like Cells and Increases Their Susceptibility to Temozolomide;
- 2021 Jul: Vitamin D suppressed gastric cancer cell growth through downregulating CD44 expression in vitro and in vivo;
- 2021 Aug: An Epigenetic Signature is Associated with Serum 25-Hydroxyvitamin D in Colorectal Cancer Tumors;
- 2021 Oct: Inhibition of CYP27B1 and CYP24 Increases the Anti-proliferative Effects of 25-Hydroxyvitamin D 3 in LNCaP Cells;
- 2022 Mar: Vitamin D receptor regulates proliferation and differentiation of thyroid carcinoma via the E-cadherin-β-catenin complex.
In Vivo (Solo animale)
- 1983 Jan: 1 alpha,25-Dihydroxyvitamin D3 and 1 alpha-hydroxyvitamin D3 prolong survival time of mice inoculated with myeloid leukemia cells;
- 1986 Jul: 1,25-Dihydroxyvitamin D3 binding in estrogen-responsive rat breast tumor;
- 1990 Mar: Inhibition of angiogenesis by vitamin D3 analogues;
- 1991 Aug: A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia;
- 1992 Aug: Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro;
- 1993 Nov: Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combination;
- 1997 May: Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines;
- 1997 Oct: Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro;
- 1997 Dec: Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system;
- 1999 Jan: Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo;
- 1999 Feb: 1alpha,25-dihydroxyvitamin D3 inhibits in vitro invasiveness through the extracellular matrix and in vivo pulmonary metastasis of B16 mouse melanoma;
- 2000 ???: A protective role of dietary vitamin D3 in rat colon carcinogenesis;
- 2000 May: Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo;
- 2000 Jun: 1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1,2-dimethylhydrazine-induced colon carcinogenesis model;
- 2000 Aug: 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo;
- 2000 Nov: Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist;
- 2001 Jan: Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo;
- 2001 Mar: 1 alpha,25-Dihydroxyvitamin D(3) inhibits rat liver ultrastructural changes in diethylnitrosamine-initiated and phenobarbital promoted rat hepatocarcinogenesis;
- 2001 May: Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma;
- 2001 Dec: Combination of 1alpha,25-dihydroxyvitamin D(3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling;
- 2002 Feb: 1alpha,25-(OH)(2)-D(3) and its synthetic analogue decrease tumor load in the Apc(min) Mouse;
- 2003 Jan-Feb: Vitamin D binding protein-macrophage activating factor (DBP-maf) inhibits angiogenesis and tumor growth in mice;
- 2003 Jun: Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells;
- 2003 Aug: Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells;
- 2005 Feb: 1 alpha,25-Dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer;
- 2005 Jun: 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer;
- 2006 Jan: Anticancer effects of the novel 1alpha, 25-dihydroxyvitamin D3 hybrid analog QW1624F2-2 in human neuroblastoma;
- 2007 Jun: 1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma;
- 2007 Nov: Treatment with 1-alpha,25-dihydroxyvitamin D3 (vitamin D3) to inhibit carcinogenesis in the hamster buccal pouch model;
- 2008 Oct: Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model;
- 2009 Jan: RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects;
- 2009 Feb: Role of vitamin D receptor in the antiproliferative effects of calcitriol in tumor-derived endothelial cells and tumor angiogenesis in vivo;
- 2009 Apr: Increased UVA exposures and decreased cutaneous Vitamin D(3) levels may be responsible for the increasing incidence of melanoma;
- 2010 Feb: 25-Hydroxyvitamin D(3) is an agonistic vitamin D receptor ligand;
- 2010 Apr: Genomic vitamin D signaling in breast cancer: Insights from animal models and human cells;
- 2010 Aug: Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system;
- 2010 Aug: Inhibition of mTORC1 by RAD001 (everolimus) potentiates the effects of 1,25-dihydroxyvitamin D(3) to induce growth arrest and differentiation of AML cells in vitro and in vivo;
- 2010 Dec: 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma;
- 2010 Dec: A vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth;
- 2011 Aug: Inecalcitol, an analog of 1α,25(OH)(2) D(3), induces growth arrest of androgen-dependent prostate cancer cells;
- 2012 Feb: A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D;
- 2012 Sep: New signalling pathway involved in the anti-proliferative action of vitamin D₃ and its analogues in human neuroblastoma cells. A role for ceramide kinase;
- 2012 Nov: Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma;
- 2012 Dec: Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines;
- 2013 Feb: Regulation of motility, invasion, and metastatic potential of squamous cell carcinoma by 1α,25-dihydroxycholecalciferol;
- 2014 Sep: Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy;
- 2015 Jun: 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling;
- 2016 Jan: 1,25(OH)2D3 Deficiency Induces Colon Inflammation via Secretion of Senescence-Associated Inflammatory Cytokines;
- 2016 Jan: Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo;
- 2016 Apr: Vitamin D3 stimulates embryonic stem cells but inhibits migration and growth of ovarian cancer and teratocarcinoma cell lines;
- 2016 Apr: Vitamin D3 suppresses morphological evolution of the cribriform cancerous phenotype;
- 2017 Jan: Antiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications;
- 2017 Feb-Mar: Vitamin D Reduces Colitis- and Inflammation-Associated Colorectal Cancer in Mice Independent of NOD2;
- 2017 Sep: Calcitriol exerts an anti-tumor effect in osteosarcoma by inducing the endoplasmic reticulum stress response;
- 2017 Nov: 1,25(OH)2D3 deficiency increases TM40D tumor growth in bone and accelerates tumor-induced bone destruction in a breast cancer bone metastasis model;
- 2018 Feb: Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model;
- 2018 Mar: Depleting ovarian cancer stem cells with calcitriol;
- 2018 Apr: MEG3 Activated by Vitamin D Inhibits Colorectal Cancer Cells Proliferation and Migration via Regulating Clusterin;
- 2018 May: Reduced vitamin D receptor (VDR) expression and plasma vitamin D levels are associated with aging-related prostate lesions;
- 2019 Feb: Growth inhibition and apoptosis in colorectal cancer cells induced by Vitamin D-Nanoemulsion (NVD): involvement of Wnt/β-catenin and other signal transduction pathways;
- 2020 Jul: An enhanced chemopreventive effect of methyl donor S-adenosylmethionine in combination with 25-hydroxyvitamin D in blocking mammary tumor growth and metastasis;
- 2020 Dec: Chemopreventive effects of vitamin D 3 and its analogue, paricalcitol, in combination with 5-fluorouracil against colorectal cancer: The role of calcium signalling molecules;
- 2021 Jul: Cytoprotective Effect of Vitamin D on Doxorubicin-Induced Cardiac Toxicity in Triple Negative Breast Cancer;
- 2021 Jul: Vitamin D suppressed gastric cancer cell growth through downregulating CD44 expression in vitro and in vivo;
- 2022 Mar: Vitamin D receptor regulates proliferation and differentiation of thyroid carcinoma via the E-cadherin-β-catenin complex.
Review
- 1993 Sep: Vitamin D analogues: new regulators of cancer cell growth and differentiation;
- 1999 Feb: Vitamin D3 derivatives (deltanoids) in the treatment of tumor cell invasion;
- 1999 Jan: Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D;
- 2001 Jan-Mar: Studies of the effects of 1,25-dihydroxyvitamin D on skeletal and calcium homeostasis and on inhibition of tumor cell growth;
- 2001 Mar-May: The role of vitamin D in prostate cancer;
- 2001 Apr: Will analogs of 1,25-dihydroxyvitamin D(3) (calcitriol) open a new era in cancer therapy?;
- 2001 Dec: Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis;
- 2002 Jan: Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review;
- 2002 Mar: Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer;
- 2002 Jun: Vitamin D-related therapies in prostate cancer;
- 2002 Aug: Vitamin D and systemic cancer: is this relevant to malignant melanoma?;
- 2003 Feb: Vitamin D: A millenium perspective;
- 2003 May: Vitamin D in preventive medicine: are we ignoring the evidence?;
- 2003 Jun: The role of vitamin D and retinoids in controlling prostate cancer progression;
- 2003 Jul: Vitamin D-3 receptor as a target for breast cancer prevention;
- 2003 Nov: Vitamin D and prostate cancer prevention and treatment;
- 2004 Feb: A critical review of studies on vitamin D in relation to colorectal cancer;
- 2004 Mar: 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action;
- 2004 Mar: Calcitriol in cancer treatment: from the lab to the clinic;
- 2004 Mar: Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis;
- 2004 May: Anti-tumor activity of calcitriol: pre-clinical and clinical studies;
- 2004 Nov: The role of Vitamin D3 metabolism in prostate cancer;
- 2004 Dec: Vitamin D and skin cancer;
- 2005 May: Vitamin D and calcium deficits predispose for multiple chronic diseases;
- 2006 Feb: The role of vitamin D in cancer prevention;
- 2006 Jul-Aug: The antitumor efficacy of calcitriol: preclinical studies;
- 2006 Jul-Aug: Vitamin D compounds: clinical development as cancer therapy and prevention agents;
- 2006 Aug: Vitamin D, calcium, and breast cancer risk: a review;
- 2006 Sep: Vitamin D: its role in cancer prevention and treatment;
- 2006 Sep: Vitamin D physiology;
- 2006 Dec: Role of dihydroxyvitamin D(3) and its nuclear receptor in novel directed therapies for cancer;
- 2007 Jan-Feb: Antioxidants and Other Nutrients Do Not Interfere With Chemotherapy or Radiation Therapy and Can Increase Kill and Increase Survival, Part 1;
- 2007 Mar-Apr: Antioxidants and Other Nutrients Do Not Interfere With Chemotherapy or Radiation Therapy and Can Increase Kill and Increase Survival, Part 2;
- 2007 Sep: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics;
- 2007 Dec: Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity;
- 2008 Jan: Molecular basis of the potential of vitamin D to prevent cancer;
- 2008 Jul: Vitamin D and intervention trials in prostate cancer: from theory to therapy;
- 2008 Oct: Vitamin D's role in cell proliferation and differentiation;
- 2009 Apr: Increased UVA exposures and decreased cutaneous Vitamin D(3) levels may be responsible for the increasing incidence of melanoma;
- 2009 Jul: Vitamin D for the prevention and treatment of pancreatic cancer;
- 2009 Aug: Optimizing vitamin D status to reduce colorectal cancer risk: an evidentiary review;
- 2009 Aug: Vitamin D and differentiation in cancer;
- 2009 Sep: Calcium, vitamin D and cancer;
- 2009 Oct: Vitamin D3-driven signals for myeloid cell differentiation--implications for differentiation therapy;
- 2009 Nov: Vitamin D and Non-Hodgkin Lymphoma Risk in Adults: A Review;
- 2009 Dec: Nutrition and orthomolecular supplementation in lung cancer patients;
- 2010 Jan: Vitamin D: Proteases, protease inhibitors and cancer;
- 2010 Mar: Breast cancer survivors and vitamin D: a review;
- 2010 Jul: Vitamin D: a pleiotropic hormone;
- 2010 Jul: Vitamin D in combination cancer treatment;
- 2010 Dec: Role of Vitamin D in the Prevention of Pancreatic Cancer;
- 2011 Jan: Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer;
- 2011 Feb: Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D;
- 2011 Aug: Calcium, vitamin D and colorectal cancer chemoprevention;
- 2011 Aug: Emerging role of vitamin D in colorectal cancer;
- 2011 Aug: Why modest but widespread improvement of the vitamin D status is the best strategy?;
- 2011 Oct: Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies;
- 2011 Dec: Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer;
- 2011 Dec: Vitamin D metabolism and action in the prostate: implications for health and disease;
- 2012 Jan: Vitamin D: potential in the prevention and treatment of lung cancer;
- 2012 Jan: Vitamin D and cancer: a review of molecular mechanisms;
- 2012 Feb: Vitamin D and the immune system: new perspectives on an old theme;
- 2012 Apr: Evidence-based D-bate on health benefits of vitamin D revisited;
- 2012 Jul: Cellular and molecular effects of vitamin D on carcinogenesis;
- 2012 Oct: Molecular aspects of vitamin D anticancer activity;
- 2012 Oct: Protective role of vitamin D signaling in skin cancer formation;
- 2012 Nov: Vitamin D and breast cancer: Emerging concepts;
- 2013 Mar: Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer;
- 2013 Apr: The role of vitamin D in the carcinogenesis of breast and ovarian cancer (Article in Polish - Abstract in English);
- 2013 Jun: The Role of Vitamin D in Hematologic Disease and Stem Cell Transplantation;
- 2013 Aug: Immune regulatory activity of vitamin d3 in head and neck cancer;
- 2013 Oct: Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis;
- 2013 Dec: Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes;
- 2014 Jan: Cytochromes p450 and skin cancer: role of local endocrine pathways;
- 2014 Mar: Chemopreventive role of vitamin D in colorectal carcinoma;
- 2014 Apr: Health outcomes of vitamin D. Part I. characteristics and classic role;
- 2014 May: Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies;
- 2014 May: The role of vitamin D in reducing cancer risk and progression;
- 2014 Jun: Ovarian cancer: interplay of vitamin D signaling and miRNA action;
- 2014 Jun: The impact of vitamin D in breast cancer: genomics, pathways, metabolism;
- 2014 Sep: Health outcomes of vitamin D. Part II. Role in prevention of diseases;
- 2014 Oct: Cancer, sunlight and vitamin D;
- 2014 Oct: Modeling vitamin D actions in triple negative/basal-like breast cancer;
- 2014 Nov: Vitamin D and colon cancer;
- 2015 Jan-Mar: Possible role of vitamin D3 on the adipocyte/fibroblast trans-differentiation mediated by pancreas cancer;
- 2015 Mar: The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy;
- 2015 Apr: Targeting cancer stem cells in solid tumors by vitamin D;
- 2015 May: Vitamin D and lung cancer risk: a comprehensive review and meta-analysis;
- 2015 May: Vitamin D supplementation review and recommendations for women diagnosed with breast or ovary cancer in the context of bone health and cancer prognosis/risk;
- 2015 Jun: Vitamin D3 in cancer prevention and therapy: the nutritional issue;
- 2015 Aug: Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis;
- 2015 Dec: Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis;
- 2015 Dec: Vitamin D, Inflammation, and Colorectal Cancer Progression: A Review of Mechanistic Studies and Future Directions for Epidemiological Studies;
- 2016 Jan: Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects;
- 2016 Apr: Vitamin D and urological cancers;
- 2016 Jun: Assessment of vitamin D status - a changing landscape;
- 2016 Jun: Could Vitamin D Analogues Be Used to Target Leukemia Stem Cells?;
- 2016 Jul: Disruption of Vitamin D and Calcium Signaling in Keratinocytes Predisposes to Skin Cancer;
- 2016 Oct: Vitamin D in hematological disorders and malignancies;
- 2016 Nov: The role of vitamin D and VDR in carcinogenesis: Through epidemiology and basic sciences;
- 2017 Jan: Current knowledge on the active form of Vitamin D synthesized in the skin and its effects on malignant melanoma;
- 2017 Jan: Effects of 1,25(OH)₂D₃ on Cancer Cells and Potential Applications in Combination with Established and Putative Anti-Cancer Agents;
- 2017 Apr: Immune Modulation by Vitamin D: Special Emphasis on Its Role in Prevention and Treatment of Cancer;
- 2017 May: Endocrine actions of vitamin D in skin: Relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond;
- 2017 Jun: The Role of Vitamin D and Vitamin D Receptors in Colon Cancer;
- 2017 Jul: Identification of tumor-autonomous and indirect effects of vitamin D action that inhibit breast cancer growth and tumor progression;
- 2017 Jul: The pancreatic cancer microenvironment: A true double agent;
- 2017 Sep: The Role of Vitamin D in Thyroid Diseases;
- 2017 Dec: Vitamin D and Breast Cancer: Latest Evidence and Future Steps;
- 2018 Apr: Exploring vitamin D metabolism and function in cancer;
- 2018 Jul: Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper;
- 2018 Aug: The role of vitamin D in ovarian cancer: epidemiology, molecular mechanism and prevention;
- 2018 Aug: Vitamin D and Endometrium: A Systematic Review of a Neglected Area of Research;
- 2018 Aug: Vitamin D: And its role in breast cancer;
- 2018 Sep: Bioactive food compounds as adjuvants to breast cancer treatment: vitamin D and omega-3;
- 2018 Sep: Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment;
- 2018 Sep: The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis;
- 2018 Oct: Vitamin D supplementation and clinical outcomes in cancer survivorship;
- 2018 Nov: A New Role for Vitamin D: The Enhancement of Oncolytic Viral Therapy in Pancreatic Cancer;
- 2018 Dec: Calcitriol and cancer therapy: A missed opportunity;
- 2018 Dec: Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis;
- 2019 Jan: Role of vitamin D and vitamin D receptor (VDR) in oral cancer;
- 2019 May: Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials;
- 2019 Aug: The role of 1,25(oh)2d3 and its analogs in proliferation and differentiation of squamous cell carcinoma of the head and neck – literature review;
- 2019 Sep: 25-Hydroxyvitamin D and Total Cancer Incidence and Mortality: A Meta-Analysis of Prospective Cohort Studies;
- 2019 Nov: Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis;
- 2019 Dec: Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis;
- 2020 Jan: DAILY AND SEASONAL MITOCHONDRIAL PROTECTION: UNRAVELING COMMON POSSIBLE MECHANISMS INVOLVING VITAMIN D AND MELATONIN;
- 2020 Jan: Review of Recent Advances in Understanding the Role of Vitamin D in Reducing Cancer Risk: Breast, Colorectal, Prostate, and Overall Cancer.
- 2020 Jun: Vitamin D and Autoimmune Thyroid Diseases - a Review;
- 2020 Jul: Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications;
- 2020 Aug: Ionizing Radiation as a Source of Oxidative Stress-The Protective Role of Melatonin and Vitamin D;
- 2020 Sep: The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials;
- 2020 Nov: The role of vitamin D in head and neck cancer;
- 2020 Dec: Policing Cancer: Vitamin D Arrests the Cell Cycle;
- 2021 Feb: Association Between Vitamin D Exposure and Head and Neck Cancer: A Systematic Review With Meta-Analysis;
- 2021 Mar: Vitamin D regulation of energy metabolism in cancer;
- 2021 Apr: Effect of Vitamin D Deficiency on Liver Cancer Risk: A Systematic Review and Meta-Analysis;
- 2021 Apr: Newly-identified Pathways Relating Vitamin D to Carcinogenesis: A Review;
- 2021 May: Vitamin D: Promises on the Horizon and Challenges Ahead for Fighting Pancreatic Cancer;
- 2021 Jun: Vitamin D Intake and the Risk of Colorectal Cancer: An Updated Meta-Analysis and Systematic Review of Case-Control and Prospective Cohort Studies;
- 2021 Jul: Circulating vitamin D levels and colorectal cancer risk: A meta-analysis and systematic review of case-control and prospective cohort studies;
- 2022 Mar: Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms;
- 2022 Mar: Vitamin D and Hypoxia: Points of Interplay in Cancer.
Editoriali - Lettere al' editore
- 1992 Sep: Growth control of human colon cancer cells by vitamin D and calcium in vitro;
- 1994 Nov: Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions;
- 1996 Feb: Vitamin D3 analogue (EB 1089) inhibits in vitro cellular proliferation of human colon cancer cells;
- 1996 May: Vitamin D inhibits endothelial cell migration;
- 1999 Feb: Vitamin D3 derivatives (deltanoids) in the treatment of tumor cell invasion;
- 2000 Feb: Calcium, lycopene, vitamin D and prostate cancer;
- 2001 May: 25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue;
- 2007 Mar: The urgent need to recommend an intake of vitamin D that is effective;
- 2008 Jun: Shedding light on colorectal cancer prognosis: vitamin d and beyond;
- 2009 Mar: Vitamin D, calcium, and colorectal neoplasia: new insights on mechanisms of action;
- 2009 May: Vitamin D in cancer patients: above all, do no harm;
- 2009 Sep: Vitamin D analogs in cancer prevention and therapy: an ancient friend revisited;
- 2010 Jul: Decreased 1-25 dihydroxyvitamin D(3) concentration in peripheral blood serum of patients with thyroid cancer;
- 2010 Jul: Reply: Decreased 1-25 Dihydroxyvitamin D3 Concentration in Peripheral Blood Serum of Patients with Thyroid Cancer;
- 2011 Feb: CLL: a supplementary question?;
- 2011 Aug: Evaluating Vitamin D Status in Ill Patients;
- 2012 Feb: Vitamin D: a novel player in endothelial function and dysfunction;
- 2012 Jul: Dietary calcium intake, vitamin D levels, and breast cancer risk: a dose-response analysis of observational studies;
- 2014 May: Blood 25-hydroxyvitamin D levels and overall mortality in patients with colorectal cancer: a dose-response meta-analysis;
- 2014 Sep: The physiology of vitamin D-far more than calcium and bone;
- 2017 Nov: The link between calcitriol and anticancer immunotherapy: vitamin D as the possible balance between inflammation and autoimmunity in the immune-checkpoint blockade;
- 2019 Jan: Vitamin D and Human Health;
- 2019 May: Vitamin D: should public health recommendations also consider cancer outcomes?;
- 2021 Mar: Melatonin and vitamin D: complementary therapeutic strategies for breast cancer.
Meta-Analysis
- 2004 Feb: A critical review of studies on vitamin D in relation to colorectal cancer;
- 2007 Mar: Vitamin D and prevention of breast cancer: pooled analysis;
- 2010 Jun: Meta-analysis of vitamin D, calcium and the prevention of breast cancer;
- 2011 Oct: Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies;
- 2012 Jul: Dietary calcium intake, vitamin D levels, and breast cancer risk: a dose-response analysis of observational studies;
- 2013 Jun: Serum 25-hydroxyvitamin D and Breast Cancer Risk: A Meta-Analysis of Prospective Studies;
- 2013 Oct: Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis;
- 2014 Mar: Meta-analysis of vitamin D sufficiency for improving survival of patients with breast cancer;
- 2014 Apr: Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis;
- 2014 May: Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies;
- 2015 May: Vitamin D and lung cancer risk: a comprehensive review and meta-analysis;
- 2015 Aug: Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis;
- 2015 Dec: Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis;
- 2017 Jun: Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies;
- 2017 Jun: Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes;
- 2017 Jun: Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis;
- 2018 Feb: Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis;
- 2018 Sep: Bioactive food compounds as adjuvants to breast cancer treatment: vitamin D and omega-3;
- 2018 Dec: Circulating vitamin D level and mortality in prostate cancer patients: a dose-response meta-analysis;
- 2019 May: Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials;
- 2019 Sep: 25-Hydroxyvitamin D and Total Cancer Incidence and Mortality: A Meta-Analysis of Prospective Cohort Studies;
- 2019 Nov: Additively protective effects of vitamin D and calcium against colorectal adenoma incidence, malignant transformation and progression: A systematic review and meta-analysis;
- 2019 Dec: Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis;
- 2020 Sep: The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials;
- 2021 Feb: Association Between Vitamin D Exposure and Head and Neck Cancer: A Systematic Review With Meta-Analysis;
- 2021 Apr: Effect of Vitamin D Deficiency on Liver Cancer Risk: A Systematic Review and Meta-Analysis;
- 2021 Jun: Vitamin D Intake and the Risk of Colorectal Cancer: An Updated Meta-Analysis and Systematic Review of Case-Control and Prospective Cohort Studies;
- 2022 Mar: Impact of vitamin D level at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis.
In Vivo (Su uomo: Case Reports/Series, Clinical Trials, Studi comparativi, Prove controllate, randomizzate e Studi retrospettivi)
- 1985 Oct: Alfacalcidol as a modulator of growth of low grade non-Hodgkin's lymphomas;
- 1991 Mar: Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma;
- 1994 Nov: Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions;
- 1997 Nov: Intake of selected micronutrients and risk of colorectal cancer;
- 1998 Jun: Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol);
- 1999 Jun: A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy;
- 1999 Sep: Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk;
- 2000 Oct: Prevention of renal cell carcinoma by active vitamin D3;
- 2001 Jun: A Phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation;
- 2001 Jun: Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China;
- 2001 Nov: Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patients;
- 2004 May: Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3;
- 2006 Feb: Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in advanced non-small-cell lung cancer patients with low performance status;
- 2006 Jun: Associations between vitamin D, vitamin D receptor gene and the androgen receptor gene with colon and rectal cancer;
- 2006 Sep: Vitamin D intake and the risk for pancreatic cancer in two cohort studies;
- 2007 Jan: Calcium and Vitamin D Intake and Risk of Colorectal Cancer: The Multiethnic Cohort Study;
- 2007 Feb: Somatostatin, retinoids, melatonin, vitamin D, bromocriptine, and cyclophosphamide in chemotherapy-pretreated patients with advanced lung adenocarcinoma and low performance status;
- 2007 Mar: A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer;
- 2007 Jun: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial;
- 2008 Jun: Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer;
- 2008 Oct: Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer;
- 2008 Dec: Complete objective response to biological therapy of plurifocal breast carcinoma;
- 2008 Dec: Genetic analysis of the vitamin D receptor gene in two epithelial cancers: melanoma and breast cancer case-control studies;
- 2009 Feb: Association between serum 25(OH)D and death from prostate cancer;
- 2009 Mar: Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial;
- 2009 Jul: Triple negative breast cancer patients presenting with low serum vitamin D levels: a case series;
- 2009 Aug: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer;
- 2009 Sep: A phase II trial of calcitriol and naproxen in recurrent prostate cancer;
- 2009 Sep: Complete objective response of oesophageal squamocellular carcinoma to biological treatment;
- 2009 Sep: Dietary vitamin D and cancers of the oral cavity and esophagus;
- 2009 Sep: Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer;
- 2009 Oct: Complete objective response of neuroblastoma to biological treatment;
- 2009 Oct: Effects of vitamin d and calcium on proliferation and differentiation in normal colon mucosa: a randomized clinical trial;
- 2010 Jan: Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: a randomized clinical trial;
- 2010 Jan: Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer;
- 2010 Jan: Plasma 25-hydroxyvitamin D levels and the risk of colorectal cancer: the multiethnic cohort study;
- 2010 Apr: Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer;
- 2010 Apr: Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial;
- 2010 Jun: Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions;
- 2010 Jul: Serum vitamin D levels and survival of patients with colorectal cancer: post-hoc analysis of a prospective cohort study;
- 2010 Jul: Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma;
- 2010 Jul: Vitamin D deficiency and bone mineral density in postmenopausal women receiving aromatase inhibitors for early breast cancer;
- 2010 Sep: Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma;
- 2010 Nov: Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia;
- 2011 Feb: Pretreatment serum concentrations of 25-hydroxyvitamin D and breast cancer prognostic characteristics: a case-control and a case-series study;
- 2011 Feb: Vitamin D deficiency is a cofactor of chemotherapy-induced mucocutaneous toxicity and dysgeusia;
- 2011 Feb: Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention;
- 2011 Apr: Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer;
- 2011 Apr: Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741;
- 2011 May: The effect of various vitamin D supplementation regimens in breast cancer patients;
- 2011 Jun: Effects of supplemental vitamin D and calcium on biomarkers of inflammation in colorectal adenoma patients: a randomized, controlled clinical trial;
- 2011 Sep: The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer;
- 2012 Feb: Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study;
- 2012 Mar: Immunological modulation by 1α,25-dihydroxyvitamin D3 in patients with squamous cell carcinoma of the head and neck;
- 2012 May: Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy;
- 2012 May: The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 23 tumours of the head and neck;
- 2012 Jul: Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer;
- 2012 Oct: High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis;
- 2012 Dec: The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of lymphomas;
- 2013 Jan: Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study;
- 2013 Jan: Vitamin D levels in patients of acute leukemia before and after remission-induction therapy;
- 2013 Aug: Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes;
- 2013 Nov: The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature;
- 2013 Dec: Evaluation of the safety and efficacy of the first-line treatment with somatostatin combined with melatonin, retinoids, vitamin D3, and low doses of cyclophosphamide in 20 cases of breast cancer: a preliminary report;
- 2014 Jan: Correlates of 25-hydroxyvitamin D among Chinese breast cancer patients;
- 2014 May: Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases;
- 2014 Aug: Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer;
- 2015 Mar: Association between alterations in the serum 25-hydroxyvitamin d status during follow-up and breast cancer patient prognosis;
- 2015 May: Recurrent Glioblastoma Multiforme (grade IV – WHO 2007): a case of complete objective response achieved by means of the concomitant administration of Somatostatin and Octreotide – Retinoids – Vitamin E – Vitamin D3 – Vitamin C – Melatonin – D2 R agonists (Di Bella Method – DBM) associated with Temozolomide;
- 2015 Jul: Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer;
- 2015 Jul: High vitamin D levels increase survival rates in patients with metastatic colorectal cancer;
- 2015 Jul: Vitamin D Deficiency Is Associated With the Severity of Radiation-Induced Proctitis in Cancer Patients;
- 2015 Aug: Circulating levels of vitamin D and colorectal adenoma: A case-control study and a meta-analysis;
- 2015 Oct: 25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression;
- 2016 Jan: Congenital fibrosarcoma in complete remission with Somatostatin, Bromocriptine, Retinoids, Vitamin D3, Vitamin E, Vitamin C, Melatonin, Calcium, Chondroitin sulfate associated with low doses of Cyclophosphamide in a 14-year Follow Up. Case Report;
- 2016 Jan: Vitamin D deficiency in patients admitted to the general ward with breast, lung, and colorectal cancer in Buenos Aires, Argentina;
- 2016 Mar: Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study;
- 2016 Apr: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study;
- 2016 Jul: High prevalence of vitamin D deficiency in women with breast cancer: The first Chilean study;
- 2016 Sep: Association between serum vitamin D levels and gastric cancer: A retrospective chart analysis;
- 2016 Nov: Decreased preoperative serum 25-Hydroxyvitamin D levels in colorectal cancer are associated with systemic inflammation and serrated morphology;
- 2017 Jan: A Role for Vitamin D in the Gastro-Entero-Pancreatic Neuroendocrine Neoplasms Outcome: Report on a Series from a Single Institute;
- 2017 Jan: Effects of Long-Term Vitamin D Supplementation on Regression and Metabolic Status of Cervical Intraepithelial Neoplasia: a Randomized, Double-Blind, Placebo-Controlled Trial;
- 2017 Jan: Vitamin D deficiency is associated with a worse prognosis in metastatic melanoma;
- 2017 Feb: Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors;
- 2017 Mar: Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study;
- 2017 Jul: High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome;
- 2017 Aug: Bone health in long-term gastric cancer survivors: A prospective study of high-dose vitamin D supplementation using an easy administration scheme;
- 2017 Oct: Association of Vitamin D3 Level with Breast Cancer Risk and Prognosis in African-American and Hispanic Women;
- 2017 Nov: Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study;
- 2017 Dec: Complete objective response, stable for 5 years, with the Di Bella Method, of multiple-metastatic carcinoma of the breast.
- 2017 Dec: The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women;
- 2017 Dec: Vitamin D Deficiency Associated with Differentiated Thyroid Carcinoma: A Case- Control Study;
- 2018 Jan: Vitamin D levels in Swiss breast cancer survivors;
- 2018 Feb: Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis;
- 2018 Mar: Determinants of Plasma 25-Hydroxyvitamin D Concentrations among Breast Cancer Survivors in Korea;
- 2018 Mar: The Synergism of Somatostatin, Melatonin, Vitamins Prolactin and Estrogen Inhibitors Increased Survival, Objective Response and Performance Status In 297 Cases of Breast Cancer;
- 2018 Jul: De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival;
- 2018 Jul: Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study;
- 2018 Jul: Vitamin D deficiency in head and neck cancer patients - prevalence, prognostic value and impact on immune function;
- 2018 Jul: Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation;
- 2018 Jul: Vitamin D supplementation and survival of patients with non-small-cell lung cancer: A randomized, double-blind, placebo-controlled trial;
- 2018 Aug: The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation;
- 2018 Sep: Poor Vitamin Status is Associated with Skeletal Muscle Loss and Mucositis in Head and Neck Cancer Patients;
- 2018 Sep: Serum vitamin D decreases during chemotherapy: an Australian prospective cohort study;
- 2018 Sep: Vitamin D receptor as a marker of prognosis in oesophageal adenocarcinoma: a prospective cohort study;
- 2018 Oct: Vitamin D levels in Mediterranean breast cancer patients compared with those in healthy women;
- 2018 Dec: Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients;
- 2019 Jan: Vitamin D deficiency in cancer patients and predictors for screening (D-ONC study);
- 2019 Feb: The effect of vitamin D and E vaginal suppositories on tamoxifen-induced vaginal atrophy in women with breast cancer;
- 2019 May: Importance of the correct assessment of bone fractures in the clinical management of metastatic castration-resistant prostate cancer treated with radium-223: A case report;
- 2019 Jun: Assessing the Effect of Vitamin D Replacement on Basal Cell Carcinoma Occurrence and Recurrence Rates in Patients with Vitamin D Deficiency;
- 2019 Jun: Examining the Vitamin D Status of Children With Solid Tumors;
- 2019 Oct: Effect Modification of Vitamin D Supplementation by Histopathological Characteristics on Survival of Patients with Digestive Tract Cancer: Post Hoc Analysis of the AMATERASU Randomized Clinical Trial;
- 2019 Oct: Negative Impact of 25-hydroxyvitamin D Deficiency on Breast Cancer Survival;
- 2019 Dec: The association of serum vitamin D-binding protein and 25-hydroxyvitamin D in pre-operative and post-operative colorectal cancer;
- 2020 Feb: Effect of Vitamin D Supplementation on Survival of Digestive Tract Cancer Patients with Low Bioavailable 25-Hydroxyvitamin D levels: A Post Hoc Analysis of the AMATERASU Randomized Clinical Trial;
- 2020 Apr: Higher serum vitamin D concentrations are longitudinally associated with better global quality of life and less fatigue in colorectal cancer survivors up to 2 years after treatment;
- 2020 Jun: Association Between Variation of Circulating 25-OH Vitamin D and Methylation of Secreted Frizzled-Related Protein 2 in Colorectal Cancer;
- 2020 Jul: Low Plasma 25-Hydoxyvitamin D at Diagnosis Predicts Poor Outcomes in Patients with Bladder Cancer: A Prospective Cohort Study;
- 2020 Jul: Vitamin D Status and Gastric Cancer: A Cross-Sectional Study in Koreans;
- 2020 Oct: Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer;
- 2020 Oct: Does vitamin D deficiency predict tumour malignancy in patients with bone tumours? Data from a multi-center cohort analysis;
- 2020 Oct: Vitamin D oral gel for prevention of radiation-induced oral mucositis: a randomized clinical trial;
- 2020 Nov: Association between serum 25-hydroxy vitamin D level and gastric adenocarcinoma - a cross sectional study;
- 2020 Nov: Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial;
- 2020 Dec: Association of Hyperparathyroidism and Papillary Thyroid Cancer: A Multicenter Retrospective Study;
- 2020 Dec: Low Vitamin D Status in a Cancer Patient Population from Franconia, Germany;
- 2020 Dec: Vitamin D Status and Survival in Stage II-III Colorectal Cancer;
- 2021 Jan: Association between Vitamin D and Heart Failure Mortality in 10,974 Hospitalized Individuals;
- 2021 Mar: Vitamin D supplementation to the older adult population in Germany has the cost-saving potential of preventing almost 30,000 cancer deaths per year;
- 2021 Apr: Associations of vitamin D status with colorectal cancer risk and survival;
- 2021 Jun: Cross-sectional observational study - Investigation of vitamin D concentration in Caucasian cancer patients. what is the adequate dose of vitamin D for these patients?;
- 2021 Jul: Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer;
- 2021 Jul: High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study;
- 2021 Jul: Improving vitamin D testing and supplementation in children with newly diagnosed cancer: A quality improvement initiative at Rady Children's Hospital San Diego;
- 2021 Aug: A Randomized Trial of Calcium Plus Vitamin D Supplementation and Risk of Ductal Carcinoma In Situ of the Breast;
- 2021 Aug: An Epigenetic Signature is Associated with Serum 25-Hydroxyvitamin D in Colorectal Cancer Tumors;
- 2021 Sep: Impact of serum vitamin D on the response and prognosis in breast cancer patients treated with neoadjuvant chemotherapy;
- 2021 Oct: Can screening for low vitamin D levels prevent bone health complications in paediatric oncology patients?;
- 2021 Oct: The association between preoperative 25-OH vitamin D levels and postoperative complications in patients undergoing colorectal cancer surgery;
- 2021 Nov: Vitamin D Supplementation Regulates Postoperative Serum Levels of PD-L1 in Patients with Digestive Tract Cancer and Improves Survivals in the Highest Quintile of PD-L1: A Post Hoc Analysis of the AMATERASU Randomized Controlled Trial;
- 2021 Dec: A Phase II Multicenter Trial on High-Dose Vitamin D Supplementation for the Correction of Vitamin D Insufficiency in Patients with Breast Cancer Receiving Adjuvant Chemotherapy.